Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Early research (Phase 1)Ended earlyNCT00023790What this trial is testingPhotodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the SkinWho this might be right forBreast CancerHead and Neck CancerLymphoma+3 more Case Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)Looking for participantsNCT05269381What this trial is testingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more Mayo Clinic 138
Testing effectiveness (Phase 2)WithdrawnNCT06084845What this trial is testingTesting the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck CancerWho this might be right forHead and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell CarcinomaLaryngeal Squamous Cell Carcinoma+12 more ECOG-ACRIN Cancer Research Group
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT03057613What this trial is testingThe Addition of Pembrolizumab to Postoperative Radiotherapy in Cutaneous Squamous Cell Cancer of the Head and NeckWho this might be right forSquamous Cell Carcinoma of the Head and Neck Case Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT01979211What this trial is testingPost-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckWho this might be right forHead and Neck Cancer University of Cincinnati 24
Early research (Phase 1)Study completedNCT04870840What this trial is testingImage-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck CancerWho this might be right forLocally Advanced Head and Neck Squamous Cell CarcinomaLocally Advanced Hypopharyngeal Squamous Cell CarcinomaLocally Advanced Laryngeal Squamous Cell Carcinoma+16 more M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT03693612What this trial is testingGSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid TumorsWho this might be right forNeoplasms GlaxoSmithKline 26
Testing effectiveness (Phase 2)Looking for participantsNCT05136196What this trial is testingBiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+22 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT04242173What this trial is testingCemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCCWho this might be right forCutaneous Squamous Cell CarcinomaCutaneous Squamous Cell Carcinoma of the Head and Neck H. Lee Moffitt Cancer Center and Research Institute 3
Testing effectiveness (Phase 2)Study completedNCT03082534What this trial is testingPembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell CarcinomaWho this might be right forHNSCCLip SCCOral Cavity Cancer+9 more University of California, San Diego 78
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Not applicableStudy completedNCT00002520What this trial is testingPhysician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Eastern Cooperative Oncology Group 434
Testing effectiveness (Phase 2)Looking for participantsNCT06532279What this trial is testingTesting the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck CancerWho this might be right forClinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+38 more NRG Oncology
Large-scale testing (Phase 3)Looking for participantsNCT06992427What this trial is testingHigh-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck CancerWho this might be right forHead and Neck Squamous Cell CarcinomaStage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8+2 more Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)WithdrawnNCT01465815What this trial is testingPhase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN)Who this might be right forRecurrent Skin CancerRecurrent Squamous Cell Carcinoma of the Lip and Oral CavitySquamous Cell Carcinoma of the Skin+3 more OHSU Knight Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00006361What this trial is testingSU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and NeckWho this might be right forCarcinoma of Unknown PrimaryHead and Neck CancerNon-melanomatous Skin Cancer Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT00021125What this trial is testingRadiation Therapy in Treating Patients With Head and Neck CancerWho this might be right forHead and Neck CancerNon-melanomatous Skin Cancer Medical Research Council 460
Testing effectiveness (Phase 2)Looking for participantsNCT07115043What this trial is testingInvestigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsWho this might be right forMelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma (Skin)+6 more AstraZeneca 120